These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. New approach to improving endothelial preservation in cryopreserved arterial substitutes. Pascual G; Rodríguez M; Corrales C; Turégano F; García-Honduvilla N; Bellón JM; Buján J Cryobiology; 2004 Feb; 48(1):62-71. PubMed ID: 14969683 [TBL] [Abstract][Full Text] [Related]
27. Allogeneic heart valve storage above the glass transition at -80°C. Brockbank KG; Wright GJ; Yao H; Greene ED; Chen ZZ; Schenke-Layland K Ann Thorac Surg; 2011 Jun; 91(6):1829-35. PubMed ID: 21536250 [TBL] [Abstract][Full Text] [Related]
28. Protocols for thawing and cryoprotectant dilution of heart valves. Armitage WJ; Dale W; Alexander EA Cryobiology; 2005 Feb; 50(1):17-20. PubMed ID: 15710365 [TBL] [Abstract][Full Text] [Related]
29. Cell survival in canine aortic heart valves stored in nutrient medium. Mochtar B; van der Kamp AW; Roza-de Jongh EJ; Nauta J Cardiovasc Res; 1984 Aug; 18(8):497-501. PubMed ID: 6467267 [TBL] [Abstract][Full Text] [Related]
30. Survival of bovine fibroblasts and cumulus cells after vitrification. Gajda B; Katska-Ksiazkiewicz L; Ryńska B; Bochenek M; Smorag Z Cryo Letters; 2007; 28(4):271-9. PubMed ID: 17962831 [TBL] [Abstract][Full Text] [Related]
31. [Experimental study on mechanical properties of decellularized porcine aortic valve and effects of precoating methods of biological scaffold on histocompatibility]. Dong NG; Ye XF; Sun ZQ; Shi JW; Qiu YM; Chen JJ Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1128-31. PubMed ID: 18005619 [TBL] [Abstract][Full Text] [Related]
32. Effect of cryopreservation techniques on aortic valve glycosaminoglycans. Dainese L; Barili F; Topkara VK; Cheema FH; Formato M; Aljaber E; Fusari M; Micheli B; Guarino A; Biglioli P; Polvani G Artif Organs; 2006 Apr; 30(4):259-64. PubMed ID: 16643384 [TBL] [Abstract][Full Text] [Related]
33. The possibility of long-term cryopreservation of cultured dermal substitute. Kubo K; Kuroyanagi Y Artif Organs; 2005 Oct; 29(10):800-5. PubMed ID: 16185341 [TBL] [Abstract][Full Text] [Related]
34. Development of a cryopreservation protocol for Leydig cells. Chen GR; Ge RS; Lin H; Dong L; Sottas CM; Hardy MP Hum Reprod; 2007 Aug; 22(8):2160-8. PubMed ID: 17596277 [TBL] [Abstract][Full Text] [Related]
35. Viability studies of human valves prepared for use as allografts. Armiger LC Ann Thorac Surg; 1995 Aug; 60(2 Suppl):S118-20; discussion S120-1. PubMed ID: 7646141 [TBL] [Abstract][Full Text] [Related]
36. [Effects of cryopreservation on cellular viability and extracellular matrix of the aortic valves]. Lai Y; Zhang E; Lai D; Li Y; Xiao Z Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):983-6. PubMed ID: 15646347 [TBL] [Abstract][Full Text] [Related]
37. Characterization of ultrastructural damage of valves cryopreserved under standard conditions. Villalba R; Peña J; Luque E; Gómez Villagrán JL Cryobiology; 2001 Aug; 43(1):81-4. PubMed ID: 11812054 [TBL] [Abstract][Full Text] [Related]
38. Biochemical and cellular characterization of cardiac valve tissue after cryopreservation or antibiotic preservation. Lang SJ; Giordano MS; Cardon-Cardo C; Summers BD; Staiano-Coico L; Hajjar DP J Thorac Cardiovasc Surg; 1994 Jul; 108(1):63-7. PubMed ID: 7661901 [TBL] [Abstract][Full Text] [Related]
39. Effect of cryopreservation on the presence of endothelial cells on human valve allografts. Lupinetti FM; Tsai TT; Kneebone JM; Bove EL J Thorac Cardiovasc Surg; 1993 Nov; 106(5):912-7. PubMed ID: 8231215 [TBL] [Abstract][Full Text] [Related]
40. Immunogenicity, antigenicity, and endothelial viability of aortic valves preserved at 4 degrees C in a nutrient medium. Lupinetti FM; Christy JP; King DM; el Khatib H; Thompson SA J Card Surg; 1991 Dec; 6(4):454-61. PubMed ID: 1815769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]